RPL23A and ovarian carcinoma: A seven-hub-molecule-signature model (RRAS2, HIST1H2BK, ALB, RPL23A, HIBCH, RPS20, and EIF3E) from those 1198 mtDEPs is established to predict the survival time of ovarian cancer.